NLARx Newsletter Header
NLARx News
September 13, 2010
In This Issue
NLARx News
Upcoming Conference
In the States
Outrage of the Week
Advertising & Marketing
Pharma Watch
PBM Watch
Pricing
Patents & Generics
Medicare & Medicaid
Safety & Clinical Trials
Conflicts of Interest
NLARx on Facebook
Quick Links
Join Our Mailing List
NLARx  in the News
For NLARx, a Victory in Docs' Drug Records Case more
Maine Voices: Doctors and Patients Don't Have to Rely on TV for Drug Information more
Upcoming Conference
2010 International Symposium on Safe Medicine's Unused Drug Return Conference, Portland, Maine, October 10-12 more
News from the States
Connecticut: Connecticut AG Supoenas Rite Aid Over Price Hikes more
Florida: State Budget Crises Mount as Medicaid Rolls Soar more
Montana: Schweitzer Cooking Up New Plan for Cheap Drugs more
Ohio: Prescription Drug Settlement to Aid Low Income Ohioans more
North Dakota: Pharmacy Measure in ND Supreme Court's Hands more
Outrage of the Week
Child's Ordeal Shows Risks of Psychosis Drugs for Young more
Advertising and Marketing
Boo! Wyeth And Its Ghostwriting Practices more
"A Drug in Search of a Disease": How Ghostwriting Helped Wyeth Sell Rormone Therapy more
FDA Ad Reviewers Too Few, Too Ill-Equipped more
FDA To Baxter: Start Telling The Truth more
Patients Worry That Pharma Taints Doctors' Decisions more
Report: Pharma Digital Spending Growing - But Slowly more
Drug Marketing - A Form of Malpractice more
Pharma Watch
Drugmakers Actually Make Lemons, Not Medicines? more
FDA To Baxter: Start Telling The Truth more
Allergan Drops FDA Lawsuit as Part of Off-Label Settlement more
Maker of Botox Settles Inquiry more
AstraZeneca Given More Time to Settle 6,000 Seroquel Lawsuits more
American Priorities: Safety, Cost & Pharma Influence more
St. Jude Medical In Settlement Talks more
Elan Pulls SEC Into Its Boardroom Spat more
PBM Watch
Company Focuses on Saving Money on Drug Prices more
Wellpoint Joins PBM Lobbyist Group more
Drug Prices and Reimbursement 
Drug Prices Rose 8 Percent Last Year: AARP more
Half Of Americans Are Taking Prescription Meds more
Roughly One In Six Cancer Survivors Forgo Some Medical Care Due To Cost, Study Finds more
Parsing the Price of Drugs more
Drug Lobby Defends Rise in Prices more
More Than a Quarter of Prescription Takers Cut Corners to Save Money more
Americans Skimp on Medicines more
Roughly One In Six Cancer Survivors Forgo Some Medical Care Due To Cost, Study Finds more
A First for Pharma: Sales were Hurt by Increased Pricing Pressure more
Why Job-Based Insurance Costs Are Soaring more
Patents and Generics
Appeals Court Upholds Pay-To-Delay Deals, Again more
Senate Bill Crucial After Court Denies Pay-for-Delay more
Court Backs Injunction Blocking Generic Versions of Lilly's Evista more
Judge Refuses To Block Generic Lovenox more
Medicare and Medicaid
Millions to Get New Drug Plans as Medicare Simplifies Program more
State Budget Crises Mount as Medicaid Rolls Soar more
Safety and Clinical Trials
Will Avandia Failure Lead to More Closely Supervised Clinical Studies and Longer Patent Life for New Drugs? more
"Making a Killing": New Carl Elliott Article in Mother Jones more
NEJM Fuels Calls to Withdraw Abbott's Meridia more
Should The FDA Have Moved Faster On Meridia? more
The FDA Is Cracking Down On Non-Inferiority Trials more
Abused Cough Meds May Get DEA Controls more
Avandia Warning Signs Seen Online as Early as '04 more
A Legal Tussle Over Adverse Event Disclosure more
NH Woman Blinded by Drug Wins $21M in Lawsuit more
FDA Boosts Warnings on Drugs Used In MRI Scans more
Independent Advisors Prove Independent more
After Fine, Botox Awaits Approval for Migraine more
Conflict of Interest, CME, and Academic Detailing
US Patients "Wary of Drugmakers' Influence Over Doctors" more 
Non-Profits And Industry Money: Who Gets What more
'No-See' Docs Will Talk To Reps At CME Meetings more
The Strings Attached to String-Free Grants more
"A Drug in Search of a Disease": How Ghostwriting Helped Wyeth Sell Rormone Therapy more
 
Subscribe to the NLARx Blog and Join us on Facebook!
For up-to-the-minute posting of news of interest and events, become a fan of NLARx on Facebook here and subscribe to our Blog.